SC
MEDP icon

Savant Capital’s Medpace MEDP Stock Holding History

Savant Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$509K Buy
1,000
+457
+84% +$211K ﹤0.01% 1207
2026
Q1 		$261K Buy
543
+88
+19% +$45.1K ﹤0.01% 1256
2025
Q4 		$256K Buy
455
+42
+10% +$23.8K ﹤0.01% 1161
2025
Q3 		$212K Buy
+413
New +$180K ﹤0.01% 1220
2025
Q1 		– Sell
-8,755
Closed -$2.91M – 1290
2024
Q4 		$2.91M Buy
8,755
+3,943
+82% +$1.34M 0.02% 338
2024
Q3 		$1.61M Sell
4,812
-1,532
-24% -$582K 0.01% 492
2024
Q2 		$2.61M Buy
6,344
+1,640
+35% +$649K 0.03% 310
2024
Q1 		$1.9M Buy
+4,704
New +$1.65M 0.02% 365

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Savant Capital's MEDP Position: Q2 2026 in Review

Savant Capital increased its Medpace (MEDP) stake by 84% in Q2 2026, buying an estimated $211K and bringing the position to 1,000 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.

Savant Capital first reported a position in MEDP in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.91M in Q4 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Savant Capital held 1,000 shares of Medpace worth $509K as of Q2 2026.
  • Savant Capital bought 457 Medpace shares in Q2 2026, an estimated $211K.
  • Medpace made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1207 holding.
  • Savant Capital first reported a position in Medpace in Q1 2024 and has held it in 8 quarters since.
  • Savant Capital's Medpace position peaked at $2.91M in Q4 2024.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.